RobertBBelsheMD

PubMed

• 1 citations
  Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzo...
  Joseph Eiden, Carlos Fierro, Alexander White, Matthew Davis, Margaret Rhee
  The Lancet. Infectious Diseases. 2024-10-01
• 7 citations
  Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women.
  Robert B Belshe, Tamara P Blevins, Yinyi Yu, Amanda E Nethington, Abbie Bellamy
  The Journal of Infectious Diseases. 2023-02-14
• 1 citations
  Platelet response to influenza vaccination reflects effects of aging.
  Anna Konstorum, Subhasis Mohanty, Yujiao Zhao, Anthony Melillo, Brent Vander Wyk
  Aging Cell. 2023-02-01

Journal Articles

• DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial  
  Ledgerwood JE, Bellamy AR, Belshe RB, Bernstein DI, Edupuganti S, Patel SM, Renehan P, Zajdowicz T,Schwartz R, Koup R, Bailer RT, Yamshchikov GV, Enama ME, Sarwar U..., PLOS ONE, 1/7/2015
• Prolonged Pro-Inflammatory Cytokine Production in Monocytes Following Influenza Vaccination is Modulated by IL-10 in Older Adults  
  Mohanty S, Joshi SR, Ueda I, Wilson J, Blevins T, Siconolfi B, Meng H, Devine L, Raddassi K, Tsang S, Belshe RB, Hafler DA, Kaech SM, Kleinstein S H, Trentalange M, Al..., J Infect Dis, 1/2/2014
• Correlate of Immune Protection against HSV-1 Genital Disease in Vaccinated Women  
  Belshe RB, Heineman TC, Bernstein DI, Bellamy AR, Ewell M, van der Most R, Deal CD, J Infect Dis, 1/1/2014
• Repertoire of Epitopes Recognized by Serum IgG from Humans Vaccinated with Herpes Simplex Virus Type 2 Glycoprotein D  
  Whitbeck J, Huang Z-Y, Cairns T, Lou H, Ponce-de-Leon M, Belshe R, Eisenberg R, Cohen G, J Virol, 1/1/2014
• Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults  
  Callahan ST, Wolff M, Hill HR, Edwards KM, NIAID Vaccine and Treatment EvaluationUnit (VTEU) Pandemic H1N1 Vaccine Study Group (including Frey SE, Belshe RB, Graham I,..., J Infect Dis, 1/1/2014
• Seroepidemiology of Astrovirus MLB1  
  Holtz LR, Bauer IK, Jiang H, Belshe R, Freiden P, Schultz-Cherry SL, Wang D., Clin Vaccine Immunol, 1/1/2014
• Phase II Randomized, Double-blinded Comparison of a Single High Dose (5x108 Tcid50) Of Modified Vaccinia Ankara Compared to a Standard Dose (1x108 Tcid50) In Healthy V...  
  Frey SE, Winokur PL, Hill H, Goll JB, Chaplin P, Belshe RB, Vaccine, 1/1/2014
• Progress toward the Development of Universal Influenza Vaccines  
  Hoft DF, Belshe RB, Missouri Medicine, 1/1/2014
• A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-genotype Neutralizing Antibodies in Humans  
  Law JLM, Chen C, Wong J, Hockman D, Santer DM, Frey SE, Belshe RB, Wakita T, Bukh J, Jones CT, Rice CM, Abrignani S, Tyrrell DL, Houghton M, PLoS One, 1/1/2013
• Seroprevalence of HSV-1 and HSV-2 Antibodies in Canadian Women Screened for Enrolment in a Herpes Simplex Virus Vaccine Trial  
  Gorfinkel IS, Aoki F, McNeil S, Dionne M, Shafran SD, Zikler P, Halperin S, Langley J, Bellamy A, Schulte J, Heineman T, Belshe R., Internatl J STD & AIDS, 1/1/2013
• Efficacy Results of a Trial of a Herpes Simplex Vaccine  
  Belshe RB, Leone PA, Bernstein DI, Wald A, Levin MJ, Stapleton JT, Gorfinkel I, Ashley Morrow RL, Ewell MG, Schulte JM, Deal CD for the Herpevac Trial for Women, New Engl J Med, 1/1/2012
• Hemagglutinin Stalk Antibodies Elicited by the 2009 Pandemic Influenza Virus as a Mechanism for the Extinction of Seasonal H1N1 Viruses  
  Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, Garcia-Sastre A, Palese P, Proc Natl Acad Sci USA, 1/1/2012
• The Safety and Efficacy of Live Attenuated Influenza Vaccine in Young Children With Asthma or Prior Wheezing  
  Ambrose CS, Dubovsky F, Yi T, Belshe RB, Ashkenazi S, Eur J Clin Microbiol Infect Dis, 1/1/2012
• Analysis of Variola and Vaccinia Neutralization Assays for Smallpox Vaccines  
  Hughes C, Newman F, Davidson W, Olson V, Smith S, Holman R, Yan L, Frey S, Belshe R, Karem K, Damon I, Clin Vacc Immunol, 1/1/2012
• Safety and Immune Responses in Children after Concurrent and Sequential 2009 H1N1 and 2009 - 2010 Seasonal Trivalent Influenza Vaccinations  
  Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur PL, Turley CB, Rupp RE, Hill H, Wolff M, Noah DL, Ross AC, Cress G, Belshe RB, J Infect Dis, 1/1/2012
• Safety and Immunogenicity of Influenza a H5 Subunit Vaccines in Adults: Effect of Vaccine Schedule and Antigenic Variant  
  Belshe RB, Frey SE, Graham I, Mulligan MJ, Edupuganti S, Jackson LA, Wald A, Poland G, Jacobson R, Keyserling HL, Spearman P, Hill H, Wolff M for the NIAID funded Vacc..., J Infect Dis, 1/1/2011
• The Relative Efficacy of Trivalent Live Attenuated and Inactivated Influenza Vaccines in Children and Adults  
  Ambrose CS, Levin MJ, Belshe RB, Influ Other Respir Vir, 1/1/2011
• Comparison of the Immunogenicity and Safety of a Split-virion, Inactivated, Trivalent Influenza Vaccine (Fluzone(R)) Administered by Intradermal and Intramuscular Rout...  
  Frenck RW Jr, Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, Hay CM, Dekker CL, Walter EB Jr, Cate TR, Edwards KM, Hill H, Wolff M, Leduc T, Tornieporth N, Vaccine, 1/1/2011
• Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, But Only Live Vaccines Induce Diverse T cell Responses in Young Children  
  Hoft DF, Babusis E, Worku S, Spencer CT, Lottenbach K, Truscott SM, Abate G, Sakala IG, Edwards KM, Creech CB, Gerber MA, Bernstein DI, Newman F, Graham I, Anderson EL..., J Infect Dis, 1/1/2011
• Phase 1 Clinical Trials of the Safety and Immunogenicity of Adjuvanted Plasmid DNA Vaccines Encoding Influenza a Virus H5 Hemagglutinin  
  Smith LR, Wloch MK, Ye M, Reyes LR, Boutsaboualoy S, Dunne CE, Chaplin JA, Rusalov D, Rolland AP, Fisher CL, Al-Ibrahim MS, Kabongo ML, Steigbigel R, Belshe RB, Kitt E..., Vaccine, 1/1/2010
• A High Dosage Influenza Vaccine Induced Significantly More Neuraminidase Antibody than Standard Vaccine among Elderly Subjects  
  Cate TR, Rayford Y, Nino D, Winokur P, Brady R, Belshe R, Chen W, Atmar RL, Couch RB, Vaccine, 1/1/2010
• Pandemic 2009 H1N1 Vaccine Protects against 1918 a Spanish Influenza Virus  
  Medina RA, Manicassamy B, Stertz S, Seibert CW, Hai R, Belshe RB, Frey SE, Basler CF, Palese P, Garcia-Sastre A, Nat Commun, 1/1/2010
• Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults  
  Frey SE, Houghton M, Coates S, Abrignani S, Chien D, Rosa D, Pileri P, Ray R, Di Bisceglie AM, Rinella P, Hill H, Wolff MC, Schultze V, Han JH, Scharschmidt B, Belshe RB, Vaccine, 1/1/2010
• Evaluation of Smallpox Vaccines Using Variola Neutralization  
  Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, Holman RC, Frey SE, Newman F, Belshe RB, Yan L, Karem K, J Gen Virol, 1/1/2009
• Safety and Immunogenicity of a Subvirion Inactivated Influenza A/H5N1 Vaccine with or without Aluminum Hydroxide among Healthy Elderly Adults  
  Brady R, Treanor JJ, Atmar RA, Keitel WA, Edelman R, Chen WH, Winokur P, Belshe R, Graham IL, Noah DL, Guo K, Hill H, Vaccine, 1/1/2009
• Join now to see all

Books/Book Chapters

• Vaccines 
  Chapter: Influenza Vaccine – Live 
  Page 291 - 309Belshe RB, Walker R, Stoddard JJ, Kemble G, Maassab HF, Mendelman PMEditors: Plotkin S, Orenstein W, Offit P.Elsevier Inc.Edition Fift,2008
• Vaccines 
  Chapter: Influenza Vaccine-Live 
  Page 371 - 388Belshe RB, Maassab HF, Mendelman PMEditors: Plotkin SA, Orenstein WA.Edition Four,2004
• Immunology and Allergy Clinics of North America – Vaccines in the 21st Century 
  Chapter: Safety and Efficacy of Live Attenuated, Cold-adapted, Influenza Vaccine-trivalent 
  Page 745 - 767Belshe RB, Mendelman PMEditors: Poland GA, guest ed.WB Saunders Company, Philadelphia2003
• Symposium in Immunology VII - Vaccination 
  Chapter: Vaccines for the Twenty-First Century 
  Page 113 - 120Belshe RBEditors: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U..Springer-Verlag, Berlin Heidelberg1998
• Mucosal Vaccines 
  Chapter: Parainfluenza Virus Vaccine 
  Page 311 - 323Belshe R, Newman F, Ray R.Editors: H. Kiyono, P.L. Ogra, J.R. McGhee.Academic Press, Inc., San Diego, CA1996
• Principles and Practice of Infectious Disease 
  Chapter: Parainfluenza Viruses 
  Henrickson K, Ray R, Belshe REditors: Mandell, G.L., Bennett, J.E., and Dolin, R..Edition 4th,1995
• Manual of Clinical Laboratory Immunology 
  Chapter: Respiratory Syncytial Virus and the Parainfluenza Viruses 
  Page 582 - 589Mufson MA and Belshe RBEditors: Rose, N.R., de Marcio, E.C., Fahey, J.L., Friedman, H., Penn, G.M..American Society for Microbiology, Washington, DCEdition 4th,1992
• Textbook of Human Virology 
  Editors: Belshe RB.Mosby Year Book, St. Louis, MOEdition Seco,1991
• Conn's Current Therapy 
  Chapter: Treatment of Influenza 
  Page 32 - 33Belshe RBEditors: Rakel.W.B. Saunders1985
• Vaccines 85: Modern Approaches to Vaccines: Molecular and Chemical Basis of Resistance to Viral, Bacterial, and Parasitic Diseases 
  Chapter: Rhesus Rotavirus: A Candidate Vaccine for Prevention of Human Rotavirus Disease 
  Page 357 - 367Kapikian AZ, Midthun K, Hoshino Y, Flores J, Wyatt RG, Glass RI, Askaa J, Nakagomi O, Nakagomi T, Chanock RM, Levine MM, Clements ML, Dolin R, Wright PF, Belshe RB, An...Cold Spring Harbor Laboratory, New York1985
• Textbook of Human Virology 
  Editors: Belshe RB.PSG Publishers, Inc., Littleton, MA1984
• Textbook of Human Virology 
  Chapter: Influenza Viruses 
  Page 267 - 297Van Voris LP, Young JF, Bernstein JM, Graham WC, Anderson EL, Gorse GJ, Belshe RBEditors: Belshe, R.B..John Wright, PSG, Inc., Littleton, MA1984
• Textbook of Human Virology 
  Chapter: Respiratory Syncytial Virus 
  Page 361 - 383Belshe RB, Bernstein JM, Dansby KNEditors: Belshe, R.B..John Wright, PSG, Inc., Littleton, MA1984
• Manual of Clinical Immunology 
  Chapter: Respiratory Syncytial Virus and the Parainfluenza Viruses 
  Page 639 - 645Mufson MA and Belshe RBAmerican Society for Micro¬biologyEdition 2nd,1980
• Current Therapy 
  Chapter: Viral Respiratory Infection 
  Belshe RBEditors: Conn, H.F..W.B. Saunders, Co.Edition 31st,1979
• Options for the Control of Influenza IV 
  Chapter: Efficacy and Effectiveness of Attenuated, Cold-adapted, Trivalent Intranasal Influenza Vaccine. 
  Belshe RBEditors: Osterhaus, A, Cox, N., Hampson, A.W..
• Join now to see all

Abstracts/Posters

• Efficacy of Live Attenuated Influenza Vaccine against Moderate to Severe versus Mild Influenza Illness in Children
  Ambrose C, Belshe RB., Pediatric Academic Societies’ Annual Meeting, Washington, DC, 1/4/2013
• Safety and Immune Responses in Children Ages 6 Months through 17 Years after Administration of Concurrent and Sequential Sanofi Pasteur’s 2009 H1N1 Vaccine and 2009-20...
  Frey SE, Bernstein DI, Gerber MA, Keyserling HL, Munoz FM, Winokur P, Turley CB, Hill H, Belshe RB, 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, BC, Canada, 1/21/2010
• Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
  Ray R, Meyer K, Banerjee A, Basu A, Coates S, Abrignani S, Houghton M, Frey SE, Belshe RB, 17th International Meeting on Hepatitis C Virus and Related Viruses (HCV 2010), Yokohama, Japan, 1/11/2010
• Societal Impact of Influenza in Children: Analysis of Four Randomized Controlled Studies
  Heikkinen T, Ashkenazi S, Belshe RB, Ambrose CS, Moren S, Zheng W, The 28th Annual meeting of the European Society for Paediatric Infectious Diseases, Nice, France, 1/4/2010
• Relative Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination
  Belshe RB, Ambrose CS, Wu X., Pediatric Academic Societies’ Annual Meeting, Vancouver, BC, Canada, 1/1/2010
• Severity of Breakthrough Influenza Illness among Children and Adults Receiving Live Attenuated and Inactivated Influenza Vaccines
  Belshe RB, Ambrose CS, Pediatric Academic Societies’ Annual Meeting, Vancouver, BC, Canada, 1/1/2010
• Independent Effects of Age and MIF Genotype of Human Monocyte TLR4 Expression.
  Panda A, Leng L, van Duin D, Wen-Kui W, Towel V, Newman FK, Belshe RB, Allore HG, Bucala R, Shaw AC, 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, PA, 1/29/2009
• Influenza-associated Antibiotic Use in Children Receiving Live Attenuated Influenza Vaccine Compared with Inactivated Influenza Vaccine
  Belshe RB, Ambrose CS, Yi T., 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, PA, 1/29/2009
• Evaluation of Smallpox Vaccines Using Variola Neutralization.
  Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, Holman RC, Frey SE, Newman F, Belshe RB, Yan L, Karem M, 47th Annual Meeting of the Infectious Diseases Society of America (IDSA), Philadelphia, PA, 1/29/2009
• Safety, Tolerability, and Immunogenicity of Bivalent Influenza Peptide Conjugate Vaccine (BIPCV) In Healthy Adults.
  Belshe RB, Treanor J, Winther B, Graham I, Mogg R, Evans B, Wiedmann R, Lyon M, Welebob C, Liang X, Shaw E, Dekleva M, Manger W, Schodel F, Musey L., The Twelfth Annual Conference on Vaccine Research, Baltimore, MD, 1/27/2009
• Evaluation of Mixed Schedules of Live Attenuated and Inactivated Influenza Vaccines in Children
  Babusis E, Belshe RB, Edwards KM, Creech II CB, Gerber MA, Bernstein DI, Newman F, Graham I, Anderson EL, The Twelfth Annual Conference on Vaccine Research, Baltimore, MD, 1/27/2009
• Live Attenuated Influenza Vaccine (LAIV), but Not Trivalent Inactivated Vaccine (TIV), Induces Functional CD4+ CD8+ and gamma delta T Cell Responses in Children Releva...
  Hoft DF, Worku S, Lottenbach K, Stanley J, Spencer C, Babusis E, Creech II CB, Edwards KM, Gerber MA, Bernstein DI, Belshe RB, The Twelfth Annual Conference on Vaccine Research, Baltimore, MD, 1/27/2009
• Saving Costs from Influenza Immunization among Young Children - Live Attenuated vs. Inactivated Influenza Vaccination
  Rousculp MD, Quon P, Belshe RB, Woodward TC, Luce B, Mahadevia PJ, ISPOR 14th Annual International Meeting, Orlando, Florida, 1/16/2009
• Efficacy of Live Attenuated Influenza Vaccine (LAIV) By Age in Children 6 Months to 17 Years of Age
  Belshe RB, Toback SL, Moren S, Ambrose CS, Yi T, 50th Annual Meeting of the European Society for Paediatric Research, Hamburg, Germany, 1/9/2009
• Quantitative Influenza Virus Shedding in Young Children with Breakthrough Influenza Illness: Data from a Randomized Controlled Trial of Two Vaccines
  Belshe R, Wang K, Ambrose CS, Walker R, Wu W, Kemble G., 50th Annual Meeting of the European Society for Paediatric Research, Hamburg, Germany, 1/9/2009
• "Efficacy of Live Attenuated Influenza Vaccine (LAIV) By Age in Children 6 Months to 17 Years of Age". Influenza-associated Antibiotic Use in Children Receiving Live ...
  Belshe R, Toback S, Ambrose CS, Yi T, Pediatric Academic Societies Annual Meeting, 1/2/2009
• Influenza-associated Antibiotic Use in Children Receiving Live Attenuated Influenza Vaccine Compared to Inactivated Influenza Vaccine
  Belshe R, Ambrose CS, Yi T., Pediatric Academic Societies Annual Meeting, Baltimore, MD, 1/2/2009
• Benefits versus Risks of Live Attenuated Influenza Vaccine (LAIV) In Young Children.
  Oster G, Nichol K, Belshe R, Klein J, Weycker D, 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, 1/25/2008
• Vaccinia Virus Membrane Protein Antibody Responses to LC16m8
  Lawrence SJ, Lottenbach KR, Empig C, Newman FK, Belshe RB, Gurwith M, Yokie H., Stanley SL Jr, Frey SE., 10th Annual Conference on Vaccine Research, Baltimore, MD, 1/30/2007
• Comparison of the Efficacy and Safety of Cold-adapted Influenza Vaccine, Trivalent (CAIV-T) With Trivalent Inactivated Influenza Vaccine (TIV) In Children 6-59 Months ...
  Belshe R, for the Influenza Vaccine Comparison Trial Group, Pediatric Academic Societies’ Annual Meeting, San Francisco, CA, 1/29/2006
• Modified Vaccinia Ankara (MVA): Development and Qualification of an Enzyme-linked Immunosorbent Assay (ELISA) For Binding Antibody
  Newman FK, Mandava M, Blevins T, Yu Y, Gormley B, Dueker C, Lottenbach K, Frey SE, Belshe RB, The 4th Annual ASM Biodefense Research Meeting, Washington, DC, 1/15/2006
• Immunogenicity of Cold-adapted Influenza Vaccine, Trivalent (CAIV-T) Compared with Trivalent Inactivated Influenza Vaccine (TIV) In Children 6-35 Months of Age
  Belshe RB, Walker R, Yi T, Hultquist M, Kemble G, Conor E, for the Influenza Vaccine Comparative Immunogenicity Trial Group, 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Canada, 1/12/2006
• A Phase 1 Trial of a Novel E1E2/MF59C.1 Hepatitis C Vaccine Candidate in Healthy HCV-negative Adults (DMID 01-002).
  Frey SE, Gorse GJ, DiBisceglie AM, Rosa D, Stamataki Z, McKeating Ray R, Coates S, Schultze V, Abrignan S, Houghton M, Hill H, Belshe RB, 12th International Symposium on Viral Hepatitis and Liver Disease, Paris, France, 1/1/2006
• A Phase I Safety and Immunogenicity Trial of a Novel E1E2/MF59C.1 Hepatitis C Vaccine Candidate in Healthy HCV-negative Adults
  DiBisceglie AM, Frey S, Gorse GJ, Ray R, Houghton M, Schultze V, Abrignani S, Coates S, Belshe R, 56th Annual – The Liver Meeting, San Francisco, CA, 1/11/2005
• Vaccinia Membrane Protein Antibody Kinetics After Smallpox Vaccination
  Lawrence SJ, Lottenbach KR, Newman FK, Buller RM, Bellone C, Stanley, Jr, SL, Belshe RB, Frey SE, 8th Annual Vaccine Conference, Baltimore, 1/9/2005
• Join now to see all

Lectures

• Pandemic Influenza: Science to Policy 
  1/1/2006
• Influenza Virus Infection: Immunity and Mucosal Vaccines 
  University at Buffalo – The State University of New York - 1/1/2003
• Rhesus Rotavirus: A Candidate Vaccine for Prevention of Human Rotavirus Disease 
  1/1/1984
• Efficacy and Effectiveness of Attenuated, Cold-adapted, Trivalent Intranasal Influenza Vaccine. 
  The Netherlands
• Join now to see all

Other

• A 4-Year-Old Boy With a History of Mild Wheezing. Patient Case Study 
  Belshe RB, myCME, Haymarket Medical Education
  1/1/2014
• Meeting the Challenge of Respiratory Syncytial Virus Infections 
  Belshe RB, Checchia PA, Vindico Medical Education, Infectious Diseases in Children
  1/1/2013
• Influenza Vaccination in Children: Efficacy and Effectiveness. 
  Belshe RB, Vaccinating Schoolchildren: Next Step Forward in the Battle against Influenza?, 27th Annual Meeting
  Brussels, Belgium - 1/31/2010
• The State of Influenza Vaccination in Children in 2008 
  Belshe RB, Prevention & Control of Pediatric Influenza, VINDICO Medical Education
  1/1/2009
• Immunizations 
  Storch GA, Belshe RB, Edwards KM, Pediatric Update, Washington University School of Medicine and Children’s Hospital, St. Louis, MO
  1/1/2008
• Influenza prevention and Treatment: The Advisory Committee on Immunization Practices 2008 Guidelines 
  Belshe RB, Influenza prevention and Treatment: The Advisory Committee on Immunization Practices 2008 Guideline
  1/1/2008
• Mechanisms of and Potential for Pandemic Influenza 
  Belshe RB, Influenza Vaccines: The Next Generation. Infectious Diseases in Children
  1/1/2007
• Structure and Strains of the Influenza Virus 
  Belshe RB, Pediatric Influenza Vaccine: New Strategies and Clinical Advice, VINDICO Medical Education
  1/1/2007
• Influenza Vaccine: State of the Art, State of the Science 
  Belshe RB, New Approaches to Influenza Vaccine Production: Meeting the Challenge, Center for Accredited Health
  1/1/2007
• New Strategies and Emerging Technologies: Progress in the Development of Modern Influenza Vaccines 
  Belshe RB, New Approaches to Influenza Vaccine Production: Meeting the Challenge, Center for Accredited Health
  1/1/2007
• Join now to see all